Kymera Therapeutics, Inc. 2026 Q1 – Outcomes – Earnings Name Presentation (NASDAQ:KYMR) 2026-05-04
Q1: 2026-04-30 Earnings AbstractEPS of -$0.71 beats by $0.15 | Income of $34.37M (55.50% Y/Y) beats by $26.14MThis text was written...
Kymera
Q1: 2026-04-30 Earnings AbstractEPS of -$0.71 beats by $0.15 | Income of $34.37M (55.50% Y/Y) beats by $26.14MThis text was written...
